Krazati - Adagrasib 200 mg / 1 Tablet 1 Bottle

Reference details for licensed healthcare facility review and verification.

adagrasib NDC Family 80739-0812 adagrasib 200 mg / 1

NDC 11	80739-0812-18
Product NDC	80739-0812
Generic Drug Name	adagrasib
Brand Name	Krazati
Manufacturer	Mirati Therapeutics, Inc
Strength	200 mg / 1
Dosage Form	Tablet
Drug Type	Oral
Package Quantity	1 Bottle
Package Description	1 BOTTLE in 1 CARTON (80739-812-18) / 180 TABLET, COATED in 1 BOTTLE
Active Ingredients	Adagrasib
Marketing Category	NDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this exact presentation or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other exact NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

adagrasib 200 mg / 1 Tablet is tracked under NDC 80739-0812-18 and rolls up into product family 80739-0812. Use this page to confirm the exact presentation before comparing related family pages or starting a quote review.

Package configuration: 1 Bottle.
Manufacturer: Mirati Therapeutics, Inc.
Dosage form: Tablet.
Family size: 2 indexed presentations.

Click a tag to refine the catalog view around this exact presentation.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Alternate presentations in this family

These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Krazati - Adagrasib 200 mg / 1 Tablet 1 BottleNDC 80739-0812-12 | 1 Bottle | Mirati Therapeutics, Inc

Krazati - Adagrasib 200 mg / 1 Tablet 1 Bottle, NDC 80739-0812-18, is a Mirati Therapeutics, Inc 200 mg / 1 tablet presentation packaged as 1 Bottle.

NDC search formats

Canonical NDC 11: 80739-0812-18
Digits-only NDC 11: 80739081218
Possible 10-digit display format: 80739-812-18 (8073981218)

Helpful product links

Search by brand name: Krazati
Exact NDC 11: 80739-0812-18
Product family NDC: 80739-0812
Compare related presentations: Krazati - Adagrasib 200 mg / 1 Tablet 1 Bottle
VA classification code: AN900
VA classification code description: ANTINEOPLASTIC,OTHER
CMOP ID: A2144
VUID: 4041918